The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer Cells

This publication has 83 references indexed in Scilit:

• The Role of Oxidative Stress in Hormesis Induced by Sodium Arsenite in Human Embryo Lung Fibroblast (HELF) Cellular Proliferation Model
  Journal of Toxicology and Environmental Health, Part A, 2007
• Apoptotic Cell Death Induced by Low-Dose Radiation in Male Germ Cells: Hormesis and Adaptation
  Critical Reviews in Toxicology, 2007
• Docetaxel induces apoptosis in hormone refractory prostate carcinomas during multiple treatment cycles
  British Journal of Cancer, 2006
• Chemotherapy-induced epidermal growth factor receptor activation determines response to combined gefitinib/chemotherapy treatment in non–small cell lung cancer cells
  Molecular Cancer Therapeutics, 2006
• Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells
  Oncogene, 2006
• Clinical Pharmacokinetics of Docetaxel
  Clinical Pharmacokinetics, 2006
• Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo
  Clinical Cancer Research, 2005
• Pim‐1 kinase promotes inactivation of the pro‐apoptotic Bad protein by phosphorylating it on the Ser¹¹² gatekeeper site
  FEBS Letters, 2004
• Delineation of prognostic biomarkers in prostate cancer
  Nature, 2001
• Paclitaxel Induces Prolonged Activation of the Ras/MEK/ERK Pathway Independently of Activating the Programmed Cell Death Machinery
  Journal of Biological Chemistry, 2001